Characterizations and potential functions of protein arginine methyltransferase 1 in primary lung structural cells

Qingzhu Sun,Daiana Stolz,Michael Tamm,Shemin Lu,Michael Roth
DOI: https://doi.org/10.1183/13993003.congress-2015.PA3882
IF: 24.3
2015-01-01
European Respiratory Journal
Abstract:Background: Epigenetic gene regulation by Protein Arginine MethylTransferase-1 (PRMT1) was linked to inflammation and thus PRMT1 may be relevant to the pathogenesis of asthma and COPD. Objective: We investigated the expression of PRMT1 in primary bronchial mesenchymal cells of patients with asthma or COPD; and we assessed its regulation by COPD and asthma relevant cytokines. Methods: Primary human ASMC (airway smooth muscle cells) and fibroblasts, isolated from bronchial tissue of patients with COPD (n=8) or asthma (n=5) were used between passage 3-7. ASMC or fibroblasts were serum deprived overnight before being stimulated with either TNF-α, TGF-β1, PDGF-BB or IgE. The expression of PRMT1 protein was detected by western blot and qRT-PCR, and its location in lung tissue by immunohistochemistry. Results: Immunohistochemistry of COPD and asthma tissue sections showed that PRMT1 was expressed in the airway epithelium, muscle cells and fibroblasts. PRMT 1 was also expressed by isolated primary human ASMC and fibroblasts. PRMT1 expression was elevated in all ASMC and fibroblasts by TGF-β or PDGF-BB stimulation after 48hrs. TNF-α up-regulated PRMT1 only in ASMC of COPD patients after 48h, but not in ASMC of asthma or controls; meanwhile, TNF-α didn9t influence PRMT1 expression in all fibroblasts. Conclusion: We observed a disease specific expression pattern of PRMT1 in ASMC and fibroblasts from control subjects, COPD and asthma patients. Thus, we hypothesize that PRMT1 has to be considered as potential target for therapeutic or diagnosis. The next step is to characterize the regulatory mechanism(s) of PRMT1 in the two diseases.
What problem does this paper attempt to address?